Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CCRN vs HDSN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HDSN Captures Overall Composite Edge (53.2 HOLD vs 52.5 HOLD), While CCRN Leads 4–2 on Growth & Valuation Pillars

HDSN Overall Winner 6-Pillar Tally: CCRN 4 – 2 HDSN Matrix Metrics: CCRN 4 – 6 HDSN

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Cross Country Healthcare Inc (CCRN) on higher Unified Composite conviction (53.2/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while CCRN wins 4–2 across the 6-pillar growth and valuation breakdown. CCRN trades at $13.25 (47.3x Forward P/E, -0.8% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin).

  • Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. CCRN 52.5/100 HOLD) and 1.32β · 68% Vol risk profile, whereas CCRN leads top-line expansion (-17.8% YoY revenue growth, 12.61x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CCRN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.1); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CCRN vs HDSN
CCRN NASDAQ
Cross Country Healthcare Inc
Services-Help Supply Services
$13.25
+0.08% 1D
Market Cap $427.7M
TTM Revenue $1.00B
Forward P/E 47.3x
Beta / 30D Vol 0.50β · 2% Vol
Unified Composite Score
52.5 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (10.7% over 20 days), RSI 76
RSI-14: 76.1 · SMA20: $13.21 · SMA50: $13.16
HDSN NASDAQ Head-to-Head Winner
Hudson Technologies Inc
Wholesale-Machinery, Equipment & Supplies
$4.25
-3.52% 1D
Market Cap $186.5M
TTM Revenue $242M
Forward P/E 25.9x
Beta / 30D Vol 1.32β · 68% Vol
Unified Composite Score
53.2 / 100 HOLD
Tech 67.0 Fund 65.0 Flow 55.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 35
RSI-14: 34.9 · SMA20: $4.68 · SMA50: $4.99

6-Pillar Scorecard Institutional Category Breakdown (CCRN 4 – 2 HDSN)

Columns: Metric · CCRN · HDSN
1. Valuation Multiples HDSN
Forward P/E 47.3x 25.9x
Trailing P/E 126.6x 16.5x
PEG Ratio 12.61x 0.29x
EV / Revenue 0.3x 0.6x
2. Growth & Scale CCRN
Revenue Growth (YoY) -17.8% -19.7%
Earnings Growth (YoY) -78.5% -82.0%
TTM Revenue (USD) $1.00B $242M
Market Cap $427.7M $186.5M
3. Profitability & Quality HDSN
Gross Margin 20.2% 21.0%
Operating Margin -0.8% 2.0%
Net Profit Margin -9.8% -0.5%
Return on Equity (ROE) -27.0% -0.5%
4. Balance Sheet & Cash Flow CCRN
Cash Generation (TTM) $40M -$32M
Cash Flow Margin 4.0% -13.0%
Net Cash / Leverage $104M Net Cash $31M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CCRN
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 11.1% (4th %ile) 79.1% (15th %ile)
Put/Call OI Skew 0.76x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat CCRN
OpEx & R&D Intensity 21.0% of Rev ($210M) 19.0% of Rev ($46M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CCRN (4) vs HDSN (6)
Institutional Metric CCRN HDSN Criterion Row Edge
Market Capitalization
Scale
$427.7M $186.5M Larger Scale CCRN
Trailing P/E Ratio
Valuation
126.6x 16.5x Lower Multiple HDSN
Forward P/E Ratio
Valuation
47.3x 25.9x Lower Multiple HDSN
Revenue Growth (YoY)
Growth
-17.8% -19.7% Higher Growth CCRN
Operating Margin (TTM)
Profitability
-0.8% 2.0% Higher Margin HDSN
Net Profit Margin
Profitability
-9.8% -0.5% Higher Margin HDSN
Return on Equity (ROE)
Capital Efficiency
-27.0% -0.5% Higher ROE HDSN
52-Week Range Position
Momentum
77% ($7–$15) 6% ($4–$8) Stronger Trend CCRN
Beta / 30D Volatility
Risk Regime
0.50β · 2% Vol 1.32β · 68% Vol Lower Realized Risk CCRN
Unified Institutional Score
Composite Signal
52.5 / 100 (HOLD) 53.2 / 100 (HOLD) Higher Composite HDSN
Trailing 12M Revenue (USD)
Operating Scale
$1.00B $242M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
20.2% 21.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
12.61x PEG · 0.3x EV/Rev 0.29x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$40M ($104M Net Cash) -$32M ($31M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HDSN +7.92 pp
CCRN: +0.61% · HDSN: +8.53%
3M Horizon CCRN +38.01 pp
CCRN: +34.38% · HDSN: -3.63%
6M Horizon CCRN +63.09 pp
CCRN: +45.44% · HDSN: -17.65%
1Y Horizon CCRN +32.83 pp
CCRN: +21.9% · HDSN: -10.93%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CCRN Revenue HDSN Revenue CCRN Op. Margin HDSN Op. Margin Margin Leader
FY2018 $820M $170M -1.6% -25.6% CCRN
FY2019 $820M $160M -1.9% -9.7% CCRN
FY2020 $840M $150M -1.1% 4.0% HDSN
FY2021 $1.68B $190M 8.3% 21.9% HDSN
FY2022 $2.80B $330M 9.6% 40.4% HDSN
FY2023 $2.02B $290M 5.6% 27.0% HDSN
FY2024 $1.34B $240M -1.3% 12.4% HDSN
FY2025 $1.05B $250M -8.0% 7.5% HDSN

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CCRN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 11.1%
IV Percentile 4th %ile
Put/Call OI Skew 0.76x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CCRN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HDSN BREAKDOWN
90d in phase · OBV ACCUMULATION
Current IV 79.1%
IV Percentile 15th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CCRN Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $427.7M market capitalization and -0.8% operating margin.
OpEx & R&D Reinvestment 21.0% of Rev ($210M)
90D Engineering Disclosures 0 Published
HDSN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $186.5M market capitalization and 2.0% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($46M)
90D Engineering Disclosures 0 Published

Investor FAQ CCRN vs HDSN Key Questions & Quantitative Answers

As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Cross Country Healthcare Inc (CCRN) on higher Unified Composite conviction (53.2/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while CCRN wins 4–2 across the 6-pillar growth and valuation breakdown. CCRN trades at $13.25 (47.3x Forward P/E, -0.8% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin). Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. CCRN 52.5/100 HOLD) and 1.32β · 68% Vol risk profile, whereas CCRN leads top-line expansion (-17.8% YoY revenue growth, 12.61x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CCRN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.1); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CCRN leads the Growth & Scale pillar: CCRN posts -17.8% YoY revenue growth and -78.5% YoY earnings growth on $1.00B TTM revenue (20.2% gross margin, -0.8% operating margin), compared with HDSN at -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CCRN cumulative revenue shifted +28.0% while HDSN shifted +47.1%. In operating R&D and SG&A reinvestment, CCRN deploys 21.0% of Rev ($210M) (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($46M) (0 disclosures) for HDSN.

HDSN screens cheaper on headline valuation multiples. CCRN trades at 47.3x Forward P/E, 126.6x Trailing P/E, 12.61x PEG, and 0.3x EV/Revenue (4.0% FCF margin), whereas HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCRN (-27.0% ROE) versus HDSN (-0.5% ROE) capital efficiency.

In options market volatility and institutional positioning, CCRN carries 11.1% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.76x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 2% Vol realized risk). By comparison, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.